Omnicell, Inc. completed the acquisition of FDS Amplicare.
September 08, 2021
Share
Omnicell, Inc. (NasdaqGS:OMCL) entered into a definitive agreement to acquire FDS Amplicare for approximately $180 million on July 25, 2021. Purchase price is subject to customary adjustments. Omnicell will use cash available on its balance sheet to fund the transaction. FDS Amplicare recorded approximately $29 million of total revenue (unaudited) for the 12 months ended June 30, 2021. Acquisition is subject to customary closing conditions, including Hart-Scott-Rodino clearance. The transaction is expected to close in the second half of 2021. Upon closing, the transaction is expected to be immediately accretive to Omnicells non-GAAP EBITDA and non-GAAP earnings per share. Evercore served as financial advisor and provided a fairness opinion to Omnicell and Sidley Austin LLP served as legal counsel to Omnicell. Baird served as financial advisor to FDS Amplicare, and Neil Townsend and David Cosgrove of Willkie Farr & Gallagher served as legal counsel to FDS Amplicare. The Evercore team included Eduardo Mestre, Mark Hanson, Bill Anderson, Ted Omlid, AJ Berens, Dave Cahoy and Vincent Cao. A Sidley Austin LLP team led by Sara Garcia Duran and Jennifer Fitchen served as Omnicell s counsel.
Omnicell, Inc. (NasdaqGS:OMCL) completed the acquisition of FDS Amplicare on September 9, 2021. Under the terms of the transaction, the estimated closing cash is $0.86 million and assumed indebtedness is of $0.65 million.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Companyâs XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.